Show simple item record

dc.contributor.authorAjlan, Radwan
dc.contributor.authorKam, Yong
dc.contributor.authorLink, Tim
dc.date.accessioned2019-09-06T14:59:07Z
dc.date.available2019-09-06T14:59:07Z
dc.date.issued2019-09-01
dc.identifier.urihttp://hdl.handle.net/1808/29542
dc.descriptionA grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.en_US
dc.description.abstractPurpose: To illustrate a case of ocular infarction following percutaneous ethanol sclerotherapy of an orbital arteriovenous malformation. Observations: The patient is a 31-year-old female who developed ocular infarction of the left eye with light perception vision, proptosis, ophthalmoplegia, and a cherry red spot following sclerotherapy of an orbital arteriovenous malformation. Fluorescein angiography demonstrated decreased arteriolar filling with vascular leakage, indocyanine green angiography showed decreased choroidal perfusion, and optical coherence tomography revealed full thickness retinal edema. Magnetic resonance angiography and venography were negative for venous sinus thrombosis or intracranial vascular compromise. Conclusions and Importance: Ocular infarction is a rare and devastating disorder that may result in permanent vision loss. Ethanol sclerotherapy has been reported to be effective in treating arteriovenous malformations. To the best of our knowledge, this is the first report in the literature of ocular infarction following percutaneous ethanol sclerotherapy to highlight this disease with multimodal imagingen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttps://www.clinicalkey.com/#!/content/playContent/1-s2.0-S2451993618301439?scrollTo=%23hl0000102en_US
dc.rights© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).en_US
dc.rights.urihttp://creativecommons.org/licenses/BY-NC-ND/4.0/en_US
dc.subjectOcular infractionen_US
dc.subjectArteriovenous malformationen_US
dc.subjectEthanol sclerotherapyen_US
dc.subjectCherry red spoten_US
dc.subjectEthanol embolizationen_US
dc.titleOcular infarction following ethanol sclerotherapy of an arteriovenous malformationen_US
dc.typeArticleen_US
kusw.kuauthorAjlan, Radwan
kusw.kudepartmentOphtalmology/ KUMCen_US
dc.identifier.doi10.1016/j.ajoc.2019.100457en_US
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccessen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Except where otherwise noted, this item's license is described as: © 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).